Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
ANZ J Surg ; 85(10): 777-82, 2015 Oct.
Article in English | MEDLINE | ID: mdl-24251959

ABSTRACT

BACKGROUND: The aim of this study was to establish the preference and reasons for initial axillary surgery performed on women with invasive breast cancer in Australia and New Zealand using data from the Breast Surgeon's Society of Australia and New Zealand Quality Audit (BQA) according to whether sentinel lymph node (SLN) biopsy, axillary lymph node dissection (ALND) or no axillary surgery was used. METHODS: Patient data from 1999 to 2011 were categorized according to primary tumour size (≤3 cm or >3 cm) and analysed by year of diagnosis, type of initial axillary surgery and frequency of second axillary surgery following SLN biopsy. Patient age at diagnosis, health insurance status, surgeon caseload and hospital location were also examined as factors affecting the likelihood of performing different types of axillary surgery. RESULTS: Seventy thousand six hundred and eighty-eight episodes of early breast cancer with axillary surgery data were reported to the BQA in the study period. The proportion of patients undergoing SLN biopsy as the first operation increased over this period in both tumour size groups with a concomitant decline in the use of ALND as the first operation over the same interval. Elderly women (>70 years old) were four times less likely to undergo axillary surgery for their initial management when compared with women aged 41-70 years old (P < 0.001). Factors favouring ALND as the initial surgery over SLN biopsy included larger tumour size, elderly age, uninsured status and having surgery in a regional centre. CONCLUSIONS: From 1999 to 2011, SLN biopsy as the initial axillary surgery has been widely adopted by surgeons reporting to the BQA. Future evaluation of the BQA data in the following 3-5 years will be performed to monitor this progression.


Subject(s)
Breast Neoplasms/surgery , Lymph Nodes/surgery , Adult , Aged , Australia , Axilla/pathology , Axilla/surgery , Female , Humans , Lymph Node Excision/methods , Lymph Nodes/pathology , Medical Audit , Middle Aged , New Zealand , Sentinel Lymph Node Biopsy/methods
3.
ANZ J Surg ; 84(10): 735-9, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24438049

ABSTRACT

BACKGROUND: The aim of this study is to use the Breast Surgeons of Australia and New Zealand Quality Audit to evaluate the diagnostic work up and surgical treatment path for Australian women with early breast cancer in relation to geographic location. METHODS: We accessed data on patient geographic demographics, diagnostic and surgical procedures and cancer characteristics in 115,872 episodes of early breast cancer reported to the Quality Audit between 1998 and 2012. Tumour size, grade and number, lymph node positivity and lymphovascular invasion are the major prognostic factors adjusted for. RESULTS: Core biopsy is the most frequently performed diagnostic method and open biopsy the least (P=0.001). Remote locations have the highest proportion of open biopsies and cities the lowest (13.8 versus 9.8%, P=0.001). The outer regional/remote patient group has a higher likelihood of an open biopsy than city patients (odds ratio 1.5; 95% confidence interval 1.1-2.2 P=0.02). Reconstruction rates are low throughout ranging from 3 to 4% (P=0.001). Cities have the highest proportion of no surgery (1.5%, P=0.001). Cities have the highest proportion of breast conserving surgery and the remote the lowest (64.5% versus 29.9%, P=0.001). Outer regional locations have the highest proportion of mastectomies and cities the lowest (38 versus 29.9%, P=0.001). The likelihood of receiving radiotherapy is associated with geographic location of residence and geographic distribution of the radiotherapy facility (P=0.002, P=0.001). CONCLUSION: Geographic location of residence is associated with the diagnostic work up and surgical treatment of Australian women with early breast cancer.


Subject(s)
Breast Neoplasms/surgery , Australia/epidemiology , Biopsy, Needle , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Breast Neoplasms/radiotherapy , Female , Humans , Lymphatic Metastasis , Mastectomy/statistics & numerical data , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Staging , New Zealand/epidemiology , Prognosis , Residence Characteristics , Risk Factors , Treatment Outcome
4.
Breast J ; 20(1): 3-8, 2014.
Article in English | MEDLINE | ID: mdl-24164659

ABSTRACT

Based on the National Breast Cancer Audit of the Royal Australasian College of Surgeons an association between patient age and type of breast cancer surgery received has already been demonstrated. The aim of this study is to assess the patterns of surgical treatment for women with early breast cancer in relation to socioeconomic and insurance status. Data on patient demographics, diagnostic, and surgical procedures and cancer characteristics in 115,872 episodes of early breast cancer reported to the National Breast Cancer Audit between 1998 and 2012 is used for this study. Tumor size, histologic grade, number of tumors, lymph node positivity, and lymphovascular invasion are the major prognostic factors adjusted for. Reconstruction following mastectomy is the most likely surgical procedure for the higher socioeconomic and privately insured patients. Mastectomy alone is the most likely surgical procedure for the lower socioeconomic and for public patients. No surgery is the most likely surgical outcome for the lower socioeconomic and the least likely for the higher socioeconomic population. Open biopsy is the most likely diagnostic procedure for the lower socioeconomic and fine needle aspiration for the higher socioeconomic population. Socioeconomic and insurance status, are both independently associated with the types of treatment and diagnostic procedure for women with breast cancer. Opportunities present to investigate an association of these factors with morbidity and survival outcomes.


Subject(s)
Breast Neoplasms/surgery , Insurance Coverage/statistics & numerical data , Socioeconomic Factors , Australia , Breast Neoplasms/diagnosis , Breast Neoplasms/pathology , Early Detection of Cancer , Female , Humans , Mastectomy , New Zealand
5.
Breast ; 22(6): 1215-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24157405

ABSTRACT

OBJECTIVES: To use data from the BreastSurgANZ Quality Audit (BQA) to examine the patterns of completion axillary lymph node dissection (cALND) after sentinel lymph node (SLN) biopsy in women treated for early breast cancer in Australia and New Zealand and to compare it to the Australian and New Zealand guidelines in cases of both positive and negative SLN results. MATERIALS AND METHODS: Patients were sub grouped as having primary tumours ≤3 cm and >3 cm and further analysed according to year of surgery, SLN status and final nodal status where cALND was recorded. Multivariate analysis was performed examining tumour size, grade, presence of lymphovascular invasion (LVI), HER2 and oestrogen receptor status, patient age and number of positive sentinel nodes as predictors for subsequent axillary surgery. RESULTS: 14879 patients were identified from 2006 to 2010. 79.8% of patients with a positive SLN result underwent cALND. Age >70 years and a greater number of involved SLN predicted no cALND among SLN positive patients. 10.3% of patients who had a negative SLN result underwent cALND. Younger age, higher grade, lymphovascular invasion and tumour size >3 cm predicted cALND among SLN negative patients. CONCLUSIONS: According to the BQA from 2006 to 2010 the Australian and New Zealand guideline recommendations for SLN positive patients to have cALND and SLN negative patients not to have cALND were adhered to in 79.8% and 89.7% of cases respectively.


Subject(s)
Breast Neoplasms/pathology , Guideline Adherence/statistics & numerical data , Lymph Node Excision/statistics & numerical data , Lymph Nodes/pathology , Lymph Nodes/surgery , Adult , Age Factors , Aged , Australia , Axilla , Blood Vessels/pathology , Breast Neoplasms/surgery , Female , Humans , Lymph Node Excision/standards , Lymphatic Metastasis , Lymphatic Vessels/pathology , Medical Audit , Middle Aged , Neoplasm Grading , Neoplasm Invasiveness , New Zealand , Practice Guidelines as Topic , Sentinel Lymph Node Biopsy , Tumor Burden
7.
J Gerontol A Biol Sci Med Sci ; 60(7): 940-6, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16079222

ABSTRACT

OBJECTIVES: Postprandial hypotension occurs frequently in older people and may result in syncope and falls. It has recently been established that the magnitude of the fall in blood pressure is related to the rate at which glucose enters the small intestine. We addressed the hypothesis that the fall in blood pressure induced by an intraduodenal glucose infusion is influenced by the interaction of glucose with the small intestinal absorptive epithelium. METHODS: Eight healthy older participants (four male, four female, age 70.3 +/- 3.4 years) were studied on two separate occasions, in single-blind, randomized order. Participants received an intraduodenal glucose infusion (3 kcal/min) with or without guar gum (4 g) for 60 minutes (0-60 minutes), followed by 0.9% saline intraduodenally for a further 60 minutes (60-120 minutes). Blood pressure and heart rate were measured every 3 minutes. Levels of blood glucose, plasma insulin, glucagon-like peptide-1 (GLP-1), and glucose-dependant insulinotropic-polypeptide (GIP) were also determined. RESULTS: Between t = 0 and t = 30 minutes, the magnitude of the fall in systolic blood pressure (p =.03) and increase in heart rate (p =.027) were lower after guar. The blood glucose (p =.009), plasma insulin (p =.027), plasma GLP-1 (p =.018), and GIP (p <.001) responses to intraduodenal glucose were attenuated by guar. CONCLUSIONS: In healthy older participants, the magnitude of the fall in systolic blood pressure and increase in heart rate induced by intraduodenal glucose are attenuated when the exposure of glucose to the small intestinal mucosa and subsequent glucose absorption is slowed by guar.


Subject(s)
Blood Pressure/drug effects , Galactans/therapeutic use , Glucose/adverse effects , Hypotension/drug therapy , Mannans/therapeutic use , Postprandial Period/physiology , Sweetening Agents/administration & dosage , Aged , Biomarkers/blood , Blood Glucose/metabolism , Blood Pressure/physiology , Duodenum , Electrocardiography , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Gastric Inhibitory Polypeptide/blood , Glucagon/blood , Glucagon-Like Peptide 1 , Glucose/administration & dosage , Heart Rate/drug effects , Humans , Hypotension/chemically induced , Hypotension/physiopathology , Insulin/blood , Male , Peptide Fragments/blood , Plant Gums , Protein Precursors/blood , Reference Values , Single-Blind Method , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...